Carbohydrate drugs - An ongoing challenge

Chemistry and Industry (London)

Volumn , Issue 5, 1997, Pages 170-174

  McAuliffe, Joseph C ^a   Hindsgaul, Ole ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE REGENERATION;

GLYCOBIOLOGY; THERAPEUTIC DRUGS; TISSUE REPAIR;

CARBOHYDRATES;

EID: 0000084638     PISSN: 00093068     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (38)

1. Varki, A., Glycobiology, 1993, 3, 97-130
2. Witczak, Z.J., Curr. Med. Chem., 1995, 1, 392-405
3. Simon, P.M., Exp. Opin. Invest. Drugs, 1994, 3, 223-39
4. Hodgson, J., Bio/Technology, 1991, 9, 609-13
5. Musser, J.H., Ann. Rep. Med. Chem., 1992, 27, 301-10
6. Dwek, R.A., Chem. Rev., 1996, 96, 683-720
7. Ishihara, M., Fedarko, N.S., & Conrad, H.E., J. Biol. Chem., 1986, 261, 13575-80
8. Drickamer, K., in 'Molecular glycobiology' (Eds M. Fukuda & O. Hindsgaul), Oxford: IRL, 1994, 53-87
9. Lasky, L.A., Science, 1992, 258, 964-9
10. Sawada, R., Tsuboi, S., & Fukuda, M., J. Biol. Chem., 1994, 269, 1425-31
11. Koch, A.E., Halloran, M.M., Haskell, C.J., Shah, M.R., & Polverini, P.J., Nature, 1995, 376, 517-19
12. Cytel Corporation (Nasdaq: CYTL), San Diego, CA, US, press release, June 1996
13. Cytel Corporation (Nasdaq: CYTL), San Diego, CA, US, press release, 30 April 1996
14. Biomira Inc. (Nasdaq: BIOMF) (TSE, ME:BRA), Edmonton, AB, Canada, press release, 7 November 1996
15. Platt, D., & Raz, A., J. Natl CancerInst., 1992, 84, 438-42
16. Pienta, K.J., et al., ibid, 1995, 87, 348-53
17. Goss, P.E., Baptiste, J., Fernandes, B., Baker, M., & Dennis, J.W., Cancer Res., 1994, 54, 1450-7
18. Herbert, J.M., et al, Circulation Res., 1996, 79, 590-600
19. Ziegler, J., J. Natl Cancer Inst., 1996, 88, 397-9
20. Balfour, J.A., & McTavish, D., Drugs, 1993, 46, 1025-54
21. Drugs Fut., 1995, 20, 979
22. Kingma, P.J., Menheere, P.P.C.A., Sels, J.P., & Nieuwenhuijzen Kruseman, A.C., Diabetes Care, 1992, 15, 478-83
23. Zopf, D., & Roth, S., Lancet, 1996, 347, 1017-21
24. Neose Technologies, Inc. (Nasdaq: NTEC), Horsham, PA, US, press release, 21 November 1996
25. Synsorb Biotech, Inc. (TSE: SYB), Calgary, AB, Canada, press release, 24 June 1996
26. Reden, J., & Dürkheimer, W., Top. Curr. Chem., 1979, 83, 105-70
27. Kondo, S., et al, J. Antibiot., 1993, 46, 531-3
28. von Itzstein, M., et al, Nature, 1993, 363, 418-23
29. Hayden, F.G., et al, J. Am. Med. Assoc., 1996, 275, 295-9
30. Fischer, P.B., Karlsson, G.B., Dwek, R.A., & Platt, F.M., J. Virol., 1996, 70, 7153-60
31. Fischl, M.A., et al, J. Acquir. Immun. Defic. Syn., 1994, 7, 139-47
32. Keikawus, A., et al, abstract Mo.B. 1121 from the 'XIth international Conference on AIDS', Vancouver, 7-12 July 1996
33. Egger, S.F., et al. Int. J. Immunopharmac., 1996, 18, 113-26
34. Harris, C., et al, Mol. Biother., 1991, 3, 207-13
35. Babineau, T.J., et al, Ann. Surg., 1994, 220, 601-9
36. Alpha-Beta Technology (Nasdaq: ABTI), Worchester, MA, US, press release, 16 Sept 1996
37. Faught, E., et al, Neurology, 1996, 46, 1684-90
38. Schneider, J.S., et al, Neurology, 1995, 45, 1149-54